促销时间表 Acurx Pharmaceuticals, Inc.
先进的时间表
简单图表
关于公司 Acurx Pharmaceuticals, Inc.
Acurx Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, develops antibiotics to treat bacterial infections. The company's lead antibiotic candidate is ibezapolstat, a novel mechanism of action that targets the polymerase IIIC enzyme that has completed Phase IIa clinical trial to treat patients with clostridium difficile infections. 更多详情IPO date | 2021-06-25 |
---|---|
ISIN | US00510M1045 |
Industry | Biotechnology |
Sector | Health Care |
Валюта | usd |
Валюта отчета | usd |
Сайт | https://www.acurxpharma.com |
Цена ао | 2.08 |
每日价格变化: | -0.6667% (0.9) |
---|---|
每周价格变化: | +8.36% (0.825) |
每月价格变化: | -21.92% (1.145) |
3个月内价格变化: | -53.44% (1.92) |
六个月内的价格变化: | -58.61% (2.16) |
每年价格变化: | -76.66% (3.83) |
3年内价格变化: | -79.26% (4.31) |
5年内价格变化: | 0% (0.894) |
10年价格变化: | 0% (0.894) |
年初以来价格变化: | -52.45% (1.88) |
|
低估
|
效率
|
|||||||||||||||||||||||||||||||||||||
股息
|
责任
|
成长冲动
|
机构 | 体积 | 分享, % |
---|---|---|
Vanguard Group Inc | 406387 | 2.58 |
Prospect Financial Services LLC | 255150 | 1.62 |
Geode Capital Management, LLC | 112132 | 0.71 |
Blackrock Inc. | 63126 | 0.4 |
Osaic Holdings Inc | 57250 | 0.36 |
Susquehanna International Group, LLP | 53553 | 0.34 |
State Street Corporation | 28566 | 0.18 |
Td Waterhouse Canada Inc. | 18656 | 0.12 |
Northern Trust Corporation | 17153 | 0.11 |
Morgan Stanley | 16201 | 0.1 |
ETF | 分享, % | 本年盈利能力, % | 股息, % |
---|---|---|---|
iShares Micro-Cap ETF | 0.00555 | 17.09 | 1.54048 |
导师 | 职称 | 支付 | 出生年份 |
---|---|---|---|
Mr. Robert J. DeLuccia | Co-Founder & Executive Chairman | 701.54k | 1946 (79 年) |
Mr. Robert G. Shawah CPA, CPA | Co-Founder & CFO | 470.29k | 1967 (58 年) |
Mr. David P. Luci CPA, Esq., J.D. | Co-Founder, President, CEO, Corporate Secretary & Director | 1967 (58 年) |
地址: United States, Staten Island. NY, 259 Liberty Avenue - 在 Google 地图中打开, 打开 Yandex 地图
网站: https://www.acurxpharma.com
网站: https://www.acurxpharma.com